Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Annals of Pharmacotherapy|March 10, 2005
Factors associated with celecoxib and rofecoxib utilizationNigel S B Rawson, Parivash Nourjah, Stella C Grosser, et al.BMC Cardiovascular Disorders|April 5, 2012
The aging Canadian population and hospitalizations for acute myocardial infarction: projection to 2020Nigel S B Rawson, Rong Chu, Afisi S Ismaila, et al.BMC Medical Research Methodology|June 8, 2007
Developing algorithms for healthcare insurers to systematically monitor surgical site infection ratesSusan S Huang, James M Livingston, Nigel S B Rawson, et al.The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|January 9, 2004
Need for an improved submission process for listing drugs for reimbursement in Canadian provincesRoy West, E Keith Borden, Jean-Paul Collet, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 27, 2002
"Cost-effectiveness" estimates result in flawed decision-making in listing drugs for reimbursementRoy West, E Keith Borden, Jean-Paul Collet, et al.Pharmacoepidemiology and Drug Safety|September 2, 2005
Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventionsDeborah Shatin, Nigel S B Rawson, Jeffrey R Curtis, et al.Current Oncology (Toronto, Ont.)|May 24, 2024
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High PricesDavid J Stewart, John-Peter Bradford, Sandeep Sehdev, et al.Current Oncology (Toronto, Ont.)|April 26, 2024
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for ImprovementSandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, et al.Pageof 4